Artikelen door HollandBIO


HollandBIO welcomes Corbion as a new member

HollandBIO connects, represents and supports the Dutch life science sector. We are very proud that we already represent 225 companies: from start-ups, small and medium-sized companies to large companies, active in health, food or biobased economy. Today we welcome Corbion! At Corbion we preserve what matters. We champion preservation in all its forms: Preserving food […]

Geautomatiseerde videotracking en gedragsanalyse van insecten ondersteunt de veredeling van resistente plantenrassen

Noldus Information Technology kondigt de commerciële release aan van EntoLab™, een nieuw geautomatiseerd systeem voor geautomatiseerde high-throughput screening van insectengedrag, ontwikkeld in samenwerking met Wageningen University & Research. EntoLab zorgt voor een revolutie in de plantenveredeling door de geautomatiseerde identificatie van resistentie-eigenschappen van insecten en draagt ​​zo bij aan een duurzamere landbouw. Bladzuigende insecten, zoals […]

HollandBIO joins the global COVID-19 Workplace Challenge & invites you to join too!

Business is a trusted source of information, well suited to engage, inform and educate workers, their families and communities with a message that inspires confidence in vaccination and encourages acceptance and uptake as COVID-19 vaccines become available. Therefore, we pledge to hear concerns, listen to feedback, and develop vaccine literacy strategies based on science, facts […]

CEPI launches COVAX Marketplace to match buyers and sellers of critical manufacturing supplies and speed up global access to COVID-19 vaccines through COVAX

The Coalition for Epidemic Preparedness Innovations (CEPI) and COVAX partners are launching an innovative ‘marketplace’ to accelerate the global production of COVID-19 vaccine doses for COVAX by matching suppliers of critical inputs with vaccine manufacturers who urgently need them to produce vaccines for fair and equitable distribution through COVAX. This initiative is a key deliverable […]

ISA announces successful closing of EUR 26 million funding round

ISA announces the closing of a EUR 26 million funding round with participation from new investors including Invest-NL and existing investors including Regeneron. The proceeds of this round will be used to advance the lead product ISA101b towards first marketing authorization as well as to broaden the clinical pipeline of immunotherapies based on the Synthetic […]

Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol’s active metabolite

Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease, today announces the publication of new research in PLOS ONE examining the in vivo active metabolite of sonlicromanol, as a selective inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1)-mediated PGE2 synthesis in prostate cancer stem cells and its potential as a novel treatment approach […]

, ,

Kamer wil stille pandemie van antibioticaresistentie bestrijden

Mooi nieuws! Unaniem spoort de Tweede Kamer de regering aan om de ontwikkeling van nieuwe antibiotica te ondersteunen. Deze motie volgt op het recent verschenen Access to Medicine Foundation-rapport “Biotechs are saving the world form superbugs. Can they also save themselves?”. Ook nu is er namelijk al sprake van een wereldwijde “stille pandemie” van resistente […]

Qorium raises € 2.6 mln to further develop its truly sustainable cultivated leather technology

Qorium raises € 2.6 million to expand R&D to scale up its cell cultured collagen based leather technology. Brightlands Venture Partners led the investment round and was joined by an undisclosed reputed international biotech investor. Qorium is a biotechnology driven company aiming to provide the world with a premium, cell cultured collagen-based leather. Qorium was […]

Viewpoint Molecular Targeting® Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program

Viewpoint Molecular Targeting, Inc. (“Viewpoint” or the “Company”), a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging agents, announced it has entered into a collaborative partnership with Netherlands-based Pepscan Therapeutics B.V. (“Pepscan”), the all-in-one peptide service provider with proprietary peptide constraining technologies. “Pepscan is clearly a world leader in peptide discovery […]


Leestip: Universiteit, faciliteer een ondernemend ecosysteem

Universiteiten zijn een ontmoetingsplek voor ondernemers en investeerders en een veilige haven om te onderzoeken of in je goede idee ook een bedrijfje schuilt. Wat ze echter niet zouden moeten doen is durfinvesteerder spelen voor start-ups, dat is althans de raad die hoogleraar Ondernemerschap en Innovatie Dries Faems de academie meegeeft na een decennium aan […]